The Pharma Data

NOVEMBER 4, 2020

(TSX: CTX) (OTC US: CRRTF) (“Crescita” or the “Company”), a growth-oriented, innovation-driven Canadian commercial dermatology company with in-house research & development (“R&D”) and manufacturing capabilities, today announced that it has entered into an exclusive agreement with Juyou-Biotechnology Co.

Licensing 40

Licensing Licensing Dermatology Production 40

Druggist

OCTOBER 25, 2020

Calamine lotion available in the UK for management of chickenpox symptoms contain a mixture of calamine (15%) and zinc oxide (5%). Creams contain higher amounts of oil(s), and therefore are of thicker consistency. Both products have the same licensed use: symptomatic relief of mild sunburn and relief from other skin conditions.

Production 52

Production Pharmacy Licensing Licensing 52

The Pharma Data

NOVEMBER 4, 2020

Initial data from an ongoing long-term, open label extension study with CTP-543 were presented in the late-breaking news session at the European Academy of Dermatology and Venereology (EADV) Virtual Congress on October 29, 2020. Published Findings on Alopecia Areata Burden of Disease in Journal of Investigative Dermatology.

Clinical Trials 52

Clinical Trials Clinical Trials Trials Dermatology 52

XTalks

AUGUST 2, 2023

It contains the antiviral medications nirmatrelvir and ritonavir. 2) Botox Therapeutic/Cosmetic Botox, or botulinum neurotoxin, is a neurotoxic protein produced by the Clostridium botulinum bacteria. It also has a significant presence in consumer health sectors such as dermatology, nutritionals and allergy. billion in 2022.

Sales 98

Sales Manufacturing FDA Approval Life Science 98